Exicure, Inc.

US$0.95As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:XCURHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (53.42%)
Div yield —
ROE (168.37%)
Biotechnology
Beta (5Y) 3.74
PE TTM —
TSR TTM (78.41%)
Mkt cap US$6.217M
ROIC (88.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.00
5.36%
(73.23%)
Hold 7|8|12|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.02
0.02
10.83%
10.61%
19.58%
24.77%
Revenue$M
0.285
0.281
0.276
0.284
(2.71%)
(1.22%)
(0.35%)
1.46%
Peers (US$6.217M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.315
(0.068)
(0.038)
EBIT/Intx
0.720
4.692
4.649
Own earn%
35.09
(122.18)
(100.61)
Sh yield%
18.00
54.89
51.59
Owners
Insiders/Inst%
7.99
22.37
Short interest%
1.31
SBC / revenue%
1.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
11–16
$1 testx
—
Incr. ROIC%
0